Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account

Abstract

BackgroundPain is a common symptom related to inflammatory bowel disease (IBD). In addition to abdominal pain, pain can also be an extraintestinal manifestation of IBD. Pain treatment is challenging and a substantial part of IBD patients are treated with opioids. Therefore, a better knowledge on pain symptoms is crucial for a better therapeutic approach to this clinical problem.MethodsPatients of the Swiss IBD Cohort Study (SIBDCS) (n = 2152) received a questionnaire regarding pain intensity, pain localization and impact of pain on daily life and social activities. Furthermore, the questionnaire investigated the use of pain-specific medication.ResultsA vast majority of patients (71%) experienced pain during the disease course. For a substantial part of patients (49% in UC and 55% in CD) pain is a longstanding problem (>5 years). Pain in UC was of shorter duration compared to CD (p < 0.01). Abdominal pain (59.5%) and back pain (38.3%) were the main pain localizations. 67% of patients took pain medication; 24% received no pain treatment. The general quality of life was significantly lower in patients suffering of pain compared to those without pain (38 vs. 77; (-100 very bad; 100 very good) p<0.0001).ConclusionsPrevalence of pain is high in patients of the SIBDCS. It is a longstanding problem for the majority of the patients affected. Pain was found to be undertreated in the SIBDCS and was significantly associated with health-related quality of life. Thus, an increased awareness is mandatory to address this frequent complication in the course of IBD.

Patients’ views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?

“…This study represents the first analysis of our group within the SMCCV. Another analysis of our group in the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS), which was published recently, investigated pain in IBD [46]. In this study, we had a higher response rate of 59%.…”

Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases

“…7 During disease flares, pain is present in 50%-70% of patients with IBD, and the health-related quality of life (HRQOL) of these patients was reported to be significantly lower in patients suffering from pain than in those without pain. 6,7 As such, EIMs are a common problem and may significantly impact the quality of life of patients with IBD, requiring specific treatments depending on the affected organs. Therefore, successful management of EIMs is essential for improving the quality of life of patients with IBD.…”

Inhibition of Cav3.2 calcium channels: A new target for colonic hypersensitivity associated with low‐grade inflammation

“…Colonic hypersensitivity (CHS) is another feature exhibited by most patients with IBD and IBS (Lembo et al, ). Chronic abdominal pain reduces the quality of life of both IBD (Gracie et al, ; Zeitz et al, ) and IBS (Halpin & Ford, ; Nellesen, Yee, Chawla, Lewis, & Carson, ) patients. Current therapies aim to reduce inflammation in IBD and motility disturbance in IBS.…”